Want to see IN:NATCAPSUQ full AI Analyst Report?
NATCAPSUQ Stock Chart & Stats
₹145.15
-₹1.02(-0.69%)
At close: 4:00 PM EDT
₹145.15
-₹1.02(-0.69%)
Day’s Range― - ―
52-Week Range₹135.60 - ₹296.40
Previous CloseN/A
Volume10.41K
Average Volume (3M)7.35K
Market Cap
₹1.76B
Enterprise Value₹2.74K
Total Cash (Recent Filing)₹53.75M
Total Debt (Recent Filing)₹1.12B
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Oct 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.4%
Share Statistics
EPS (TTM)-6.25
Shares Outstanding10,411,154
10 Day Avg. Volume2,238
30 Day Avg. Volume7,351
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.47
Price to Sales (P/S)0.55
P/FCF Ratio-9.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthStrong FY2026 revenue expansion shows that the company is still generating demand and increasing its business scale. If management can address the accompanying cost pressure, this larger revenue base could support operating leverage and improve future earnings power.
Moderate LeverageDebt at approximately half of equity gives Natural Capsules some financial flexibility relative to a more highly levered structure. This can preserve room to fund operations or investments, although the benefit depends on restoring profitability and cash generation.
Established WorkforceA workforce of 620 employees indicates an established operating base rather than a purely early-stage organization. That personnel scale can provide ongoing capacity to run the business and execute on revenue opportunities, assuming financial pressure does not force contraction.
Bears Say
Profitability CollapseThe move from near break-even performance to a sizable net loss is a major fundamental weakness. Negative gross, operating, and EBITDA margins show that revenue growth is currently accompanied by significant cost or pricing pressure, making recovery dependent on a durable margin improvement.
Negative Free Cash FlowPersistent negative free cash flow means the business is not currently funding its operations and investments internally. Weak operating cash conversion alongside a FY2026 loss raises the possibility of external funding needs, limiting financial flexibility if weakness persists.
Weaker Balance-Sheet QualityAlthough leverage remains moderate, declining equity and negative return on equity indicate that the balance sheet is deteriorating in quality. Continued losses could further erode the capital base and reduce the company’s ability to absorb setbacks or finance growth internally.
Natural Capsules Limited News
NATCAPSUQ FAQ
What was Natural Capsules Limited’s price range in the past 12 months?
Natural Capsules Limited lowest stock price was ₹135.60 and its highest was ₹296.40 in the past 12 months.
What is Natural Capsules Limited’s market cap?
Natural Capsules Limited’s market cap is ₹1.76B.
When is Natural Capsules Limited’s upcoming earnings report date?
Natural Capsules Limited’s upcoming earnings report date is Oct 26, 2026 which is in 30 days.
How were Natural Capsules Limited’s earnings last quarter?
Natural Capsules Limited released its earnings results on Aug 12, 2026. The company reported -₹3.819 earnings per share for the quarter.
Is Natural Capsules Limited overvalued?
According to Wall Street analysts Natural Capsules Limited’s price is currently Overvalued.
Does Natural Capsules Limited pay dividends?
Natural Capsules Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.4%. See more information on Natural Capsules Limited dividends here
What is Natural Capsules Limited’s EPS estimate?
Natural Capsules Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Natural Capsules Limited have?
Natural Capsules Limited has 10,411,154 shares outstanding.
What happened to Natural Capsules Limited’s price movement after its last earnings report?
Natural Capsules Limited reported an EPS of -₹3.819 in its last earnings report. Following the earnings report the stock price went down -3.671%.
Which hedge fund is a major shareholder of Natural Capsules Limited?
Currently, no hedge funds are holding shares in IN:NATCAPSUQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Natural Capsules Limited
Natural Capsules Ltd. specializes in the production and global distribution of hard gelatin and cellulose capsule shells, catering to markets in India and abroad. The company offers a comprehensive array of capsule types, including those guaranteed free from bovine spongiform encephalopathy (BSE) and transmissible spongiform encephalopathy (TSE), shiny, sodium lauryl sulfate (SLS)-free, and halal-certified gelatin variants. Their product line further extends to fast-release, printed gelatin/cellulose, vegetarian, and enteric capsule shells. Beyond manufacturing shells, Natural Capsules Ltd. is also involved in formulating various pharmaceutical products in capsule dosage forms. Established in 1993, the company is headquartered in Bengaluru, India.
Technical Analysis
Alpa Laboratories Limited
―
Bal Pharma Limited
―
Brooks Laboratories Limited
―
Nectar Lifesciences Ltd.
―
Par Drugs and Chemicals Limited
―